Dabigatran (Pradaxa) Tablets: Uses, Interactions and Dosage
Written by Medicover Team and Medically Reviewed by Dr S Srikar Samir Nandan, Cardiology
Dabigatran is a popular blood-thinning medication that helps keep your blood flowing smoothly. It's commonly used to lower the risk of stroke and blood clots, especially in people with atrial fibrillation heart rhythm issue not linked to heart valve problems.
With its ability to prevent dangerous clots, Dabigatran offers peace of mind and adequate protection for those at risk.
Dabigatran is an anticoagulant medication, also known as a blood thinner, used primarily to reduce the risk of stroke and blood clots in people with atrial fibrillation (a heart rhythm disorder not caused by a heart valve problem).
It works by making it easier for blood to flow through veins, thereby reducing the chances of clot formation.
Dabigatran is a go-to option for preventing and treating blood clot-related issues, offering significant benefits like stroke prevention. It's versatile and prescribed for various situations where blood clots could be a problem.
Why it matters: Dabigatran helps keep your blood moving and reduces serious health risks.
The Dabigatran mechanism of action involves directly inhibiting thrombin, a key enzyme in the blood clotting process. Thrombin converts fibrinogen into fibrin, which forms the structure of blood clots.
By blocking thrombin, Dabigatran prevents fibrin formation, keeping blood thinner and reducing the risk of harmful clots. This makes it particularly effective for conditions like atrial fibrillation, where irregular heartbeats increase the risk of blood clots.
Take Dabigatran with a full glass of water. The capsules should be swallowed whole; do not crush, chew, break, or open them. The medication can be taken with or without food.
The correct dose of dabigatran depends on your condition and health history. Always follow your doctor's advice to get the best results and stay safe.
If you miss a dose, take it as soon as you remember unless it's nearly time for your next dose. Skip the missed dose and continue your regular schedule-do not double the dose.
An overdose of Dabigatran can cause serious bleeding, with symptoms like:
Get a second opinion from trusted experts and makeconfident, informed decisions.
Get Second OpinionDabigatran side effects range from mild to serious. Most patients tolerate it well, but monitoring is essential.
If any serious symptoms occur, seek immediate medical attention.
Before taking Dabigatran, inform your doctor about:
Dabigatran is approved for adults and children aged 3 months to less than 18 years for VTE treatment and prevention. Its safety in children under 3 months is not established.
Dabigatran can be taken with or without food. Moderate alcohol use is generally safe, but excessive alcohol may increase bleeding risk Mayo Clinic.
Dabigatran may interact with other medications, affecting its efficacy or increasing bleeding risk. Key interactions include:
Always inform your healthcare provider about all medications and supplements.
Keep it in its original packaging to protect it from moisture and out of reach of children. Capsules should be used within 4 months of opening, and oral pellets should be used within 6 months.
Improper storage, such as exposure to moisture or heat, can degrade Dabigatran, reducing its effectiveness or increasing the risk of side effects. Always follow storage guidelines.
| Dabigatran | Aspirin |
| Used to lower the risk of stroke in atrial fibrillation and prevent blood clots | Used as an anti-inflammatory drug to treat fever and inflammation |
| Treats blood clots in veins, including those in the lungs | Treats arthritis and other inflammatory conditions |
| Common side effects include upset stomach, heartburn, and nausea | Common side effects include nausea, vomiting, stomach pain, and heartburn |
Always consult your doctor before starting or stopping Dabigatran. Follow your prescribed dosage and discuss any concerns or side effects promptly with your healthcare provider.
For emergencies or severe reactions, seek immediate medical attention. Carry your medications with you when traveling to manage potential emergencies effectively.

Still have questions? Speak with our experts now!
040-68334455Dabigatran treatment typically lasts for 28 to 35 days after hip replacement surgery and for about 10 days after knee replacement surgery. The exact duration may vary based on your condition and your doctor’s recommendation.
No known interaction exists between Vitamin C and Dabigatran. However, it is always best to consult your doctor before taking any supplements or medications alongside Dabigatran.
No, Dabigatran is not a Factor Xa inhibitor. It is a direct thrombin inhibitor, meaning it works by directly blocking thrombin (Factor IIa), a key enzyme involved in blood clot formation.
Rivaroxaban and Dabigatran are both oral anticoagulants, but they target different clotting factors. Rivaroxaban is a Factor Xa inhibitor, while Dabigatran is a direct thrombin inhibitor (Factor IIa). They have different mechanisms of action, dosing regimens, and potential drug interactions.
Dabigatran is a direct oral anticoagulant (DOAC) and specifically a direct thrombin (Factor IIa) inhibitor. It helps prevent and treat blood clots by inhibiting thrombin, which is essential for the formation of fibrin in blood clots.
The mechanism of action of Dabigatran involves direct inhibition of thrombin (Factor IIa), an enzyme essential for the conversion of fibrinogen into fibrin, a key step in the blood clotting process. By blocking thrombin, Dabigatran effectively prevents the formation of new clots and the growth of existing ones.
Dabigatran, also known as Dabigatran Etexilate, is an oral anticoagulant used to prevent and treat blood clots. It is commonly prescribed for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used to prevent blood clots after certain surgeries, such as hip replacement.
When it comes to surgery, Dabigatran should usually be stopped 24 to 48 hours before the procedure, depending on the patient’s kidney function and the bleeding risk of the surgery. For patients with normal kidney function, it is typically stopped 24 hours before low-risk procedures and 48 hours before high-risk procedures. In those with impaired kidney function, a longer discontinuation period of 72 to 96 hours may be needed. It is important to follow a doctor’s guidance to safely manage the timing of discontinuation.
The antidote for Dabigatran is Idarucizumab, a specific reversal agent marketed under the brand name Praxbind. It is a humanized monoclonal antibody fragment that binds to Dabigatran with high affinity, neutralizing its anticoagulant effect within minutes. Idarucizumab is used in emergency situations where rapid reversal of Dabigatran is necessary, such as in cases of life-threatening bleeding or urgent surgical procedures. It is administered as an intravenous injection, typically in two consecutive 2.5 g doses (total 5 g). The use of Idarucizumab allows doctors to quickly restore normal blood clotting function in patients taking Dabigatran.
Disclaimer: The information provided is accurate and up-to-date to the best of our knowledge. However, it should not be considered a substitute for medical advice or consultation. We do not guarantee its completeness or accuracy. The absence of specific warnings does not mean a medicine is safe for all users. We are not responsible for any outcomes based on this information and strongly recommend consulting a doctor for any medical concerns or questions.